These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Concerns regarding in vitro and in vivo uses of thalidomide. Tadesse A; Shannon EJ Lepr Rev; 2005 Mar; 76(1):94-6. PubMed ID: 15881041 [No Abstract] [Full Text] [Related]
25. Thalidomide in America: a brush with tragedy. McFadyen RE Clio Med; 1976 Jul; 11(2):79-93. PubMed ID: 61093 [No Abstract] [Full Text] [Related]
26. Amenorrhea during thalidomide treatment: An unusual cause of ovarian failure? Pulido-Pérez A; Lázaro-Ochaita P; Suárez-Fernández R Med Clin (Barc); 2017 Aug; 149(3):135-136. PubMed ID: 28396134 [No Abstract] [Full Text] [Related]
27. Peripheral edema in lepromatous leprosy--could thalidomide be the culprit. Mehta V Indian J Lepr; 2008; 80(4):345-6. PubMed ID: 20329383 [No Abstract] [Full Text] [Related]
28. The return of thalidomide: new uses and renewed concerns--reply. Naafs B Lepr Rev; 2003 Sep; 74(3):294-5. PubMed ID: 14577480 [No Abstract] [Full Text] [Related]
29. Medication misuse and abuse: duties and responsibilities of dispensing pharmacists. Berland-Benhaïm C; Giocanti D; Bartoli C; Sastre C; Leonetti G; Pelissier-Alicot A Med Sci Law; 2011 Jan; 51(1):49-55. PubMed ID: 21595422 [TBL] [Abstract][Full Text] [Related]
31. Hansen's disease in an HIV patient complicated by deep vein thrombosis: a rare complication of thalidomide therapy. Medeiros S; Fernandes C; Martins N; Machado J; Kutzner H; Afonso A; Vieira R; Maltez F; Cardoso J Eur J Dermatol; 2009; 19(3):272-3. PubMed ID: 19251574 [No Abstract] [Full Text] [Related]
32. [Ethical and legal responsibility of the hospital pharmacist]. Larios D Farm Hosp; 2011; 35(6):287-8. PubMed ID: 21783397 [No Abstract] [Full Text] [Related]
33. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill. Ochs A Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540 [No Abstract] [Full Text] [Related]
35. Thalidomide: is it any wonder? Hampshire M Nurs Times; 1998 Aug 26-Sep 1; 94(34):14-5. PubMed ID: 9791503 [No Abstract] [Full Text] [Related]
36. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction. Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284 [TBL] [Abstract][Full Text] [Related]
37. Does thalidomide have a role in leprosy? Crawford CL Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644 [No Abstract] [Full Text] [Related]
38. Learn a little risk management. Manag Care Strateg; 1998 Oct; 6(10):114-6; suppl 1-2. PubMed ID: 10185963 [No Abstract] [Full Text] [Related]
39. The rehabilitation of thalidomide. MacDougall DS J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029 [TBL] [Abstract][Full Text] [Related]
40. The doctor, the pharmacist, the patient, and the placebo, or you're not my mother, doctor. Nielsen JR Food Drug Cosmet Law J; 1989 Nov; 44(6):639-57. PubMed ID: 11659226 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]